Pegaferon in hepatitis C: Results of a Multicenter Study - Wikidata - awgldk - TriplyDB

Pegaferon in hepatitis C: Results of a Multicenter Study

Pegaferon in hepatitis C: Results of a Multicenter Study

http://www.wikidata.org/entity/Q34134994

about

Epidemiology of hepatitis C virus in Iran Interferon-λ polymorphisms and response to pegylated interferon in Iranian hepatitis C patients Efficacy and Tolerability of Peginterferon alpha-2a and Peginterferon alpha-2b in Iranian Patients With Chronic Hepatitis C.Real response to therapy in chronic hepatitis C virus patients: a study from iran.Liver Disease Burden of Hepatitis C Virus Infection in Iran and the Potential Impact of Various Treatment Strategies on the Disease Burden Hepatitis C Virus: The Rising Concerns and Growing Hopes, Report From the HCV Symposium, Fourth Tehran Hepatitis Congress, November 2011, Tehran, Iran.

P2860

Q26781996-03F7A965-6E9C-4AA8-A14A-FDEC4D6EC527 Q35925546-1355B090-E6AF-4C1A-8774-547180B4A26A Q36182539-FAFA9136-E412-4385-A244-CE20F554F8BB Q36329140-89A1D37F-196D-43CD-A423-E32752D66B47 Q37246465-E31045F1-FF10-4EC0-8023-C350051A5D18 Q46923875-F5A9894D-730D-4425-8D5A-6BC2608FB2F8

P2860

Pegaferon in hepatitis C: Results of a Multicenter Study

http://www.wikidata.org/entity/Q34134994

description

2011 nî lūn-bûn

@nan

2011 թուականի Սեպտեմբերին հրատարակուած գիտական յօդուած

@hyw

2011 թվականի սեպտեմբերին հրատարակված գիտական հոդված

@hy

2011年の論文

@ja

2011年論文

@yue

2011年論文

@zh-hant

2011年論文

@zh-hk

2011年論文

@zh-mo

2011年論文

@zh-tw

2011年论文

@wuu

name

Pegaferon in hepatitis C: Results of a Multicenter Study

@ast

Pegaferon in hepatitis C: Results of a Multicenter Study

@en

Pegaferon in hepatitis C: Results of a Multicenter Study

@nl

type

label

Pegaferon in hepatitis C: Results of a Multicenter Study

@ast

Pegaferon in hepatitis C: Results of a Multicenter Study

@en

Pegaferon in hepatitis C: Results of a Multicenter Study

@nl

prefLabel

Pegaferon in hepatitis C: Results of a Multicenter Study

@ast

Pegaferon in hepatitis C: Results of a Multicenter Study

@en

Pegaferon in hepatitis C: Results of a Multicenter Study

@nl

P1433

Q34134994-97F3BC08-77BA-4DA2-961E-2A30EE235198

P1476

Q34134994-6D15CEF4-80EB-4277-A365-559F52E75C48

P2093

Q34134994-0932A98F-8D9B-49CA-96CE-B311A42B4CB3

Q34134994-2D3E4162-D1AB-43D6-ACB7-4B73D47BF503

Q34134994-4109DFFD-5CAF-4799-A284-8B7213125CE2

Q34134994-5BB3A8B1-88FF-4C90-A426-A3AE091ABA76

Q34134994-BC41C4E0-DD67-4635-A402-CF922FEEC200

Q34134994-DDB6071D-3DDE-4296-A3C9-A0CE8E7923B3

Q34134994-E5D9F0D1-5C8B-4C89-AC64-221A880E6DC0

Q34134994-EEC41140-4BCD-45DD-AF63-2D6C25EE78A4

Q34134994-F28877B2-3A27-48FD-8804-E3B8B3AF30FE

Q34134994-FCDB77EB-B580-48FB-9CDB-7D06E7ED15F2

P2860

Q34134994-0C5E4988-E344-4CAB-B427-40F712AF816D

Q34134994-164C24AA-9BAA-4318-95D7-E2011527CE4D

Q34134994-5BC04CA0-67FC-40FE-BE69-DC61BF96EC67

Q34134994-628B1894-806C-40C6-9C10-6070F606E8C1

Q34134994-6CE9E235-7997-4836-803E-BF451A2953B0

Q34134994-815E7DF0-2CAA-4881-9EF8-8D599E7ACD9C

Q34134994-96988E18-3EB9-4AB8-9F80-60C4D45B5EF1

Q34134994-99F7DDE0-4EC9-464D-9621-5A54E8FD9994

Q34134994-9F4773FB-BE69-47B4-8499-94BB11CCD0D4

Q34134994-C655E5B3-0470-4175-9E82-088EDF320547

P304

Q34134994-72F23F8C-12F7-4BD5-A2C7-FF253A808E82

P31

Q34134994-FFA641C5-6478-4F32-B7B0-ACE57C5CE584

P433

Q34134994-1E840F32-B033-4A26-94E7-DE7868D023A5

P478

Q34134994-49A5B1DC-29FA-4247-A174-C43272136CB8

P577

Q34134994-4C33D8B0-1845-4A93-BE5C-BF7D4BBF4F41

P698

Q34134994-A8A51C79-EFFE-4264-9064-54F739D3F525

P921

Q34134994-2DFBDDE3-2190-482B-ADB8-2491D6EBFA4D

P932

Q34134994-11548735-9E66-47BE-B00A-90C25C11A2A7

P1433

Middle East journal of digestive diseases

P1476

Pegaferon in hepatitis C: Results of a Multicenter Study

@en

P2093

Amir Houshang Sharfi

http://www.w3.org/2001/XMLSchema#string

Arghavan Sheikholeslami

http://www.w3.org/2001/XMLSchema#string

Elham Fakharzadeh

http://www.w3.org/2001/XMLSchema#string

Farhad Zamani

http://www.w3.org/2001/XMLSchema#string

Hedye Zamini

http://www.w3.org/2001/XMLSchema#string

Hossain Jabbari

http://www.w3.org/2001/XMLSchema#string

Khadijeh Hatami

http://www.w3.org/2001/XMLSchema#string

Kiana Shahzamani

http://www.w3.org/2001/XMLSchema#string

Reza Malekzadeh

http://www.w3.org/2001/XMLSchema#string

Shahin Merat

http://www.w3.org/2001/XMLSchema#string

P2860

Isolation of a cDNA clone derived from a blood-borne non-A, non-B viral hepatitis genome

Peginterferon alfa-2a plus ribavirin for chronic hepatitis C virus infection

Classification of hepatitis C virus into six major genotypes and a series of subtypes by phylogenetic analysis of the NS-5 region

Interferon alfa-2b alone or in combination with ribavirin as initial treatment for chronic hepatitis C. Hepatitis Interventional Therapy Group

Peginterferon-alpha2a and ribavirin combination therapy in chronic hepatitis C: a randomized study of treatment duration and ribavirin dose

Global surveillance and control of hepatitis C. Report of a WHO Consultation organized in collaboration with the Viral Hepatitis Prevention Board, Antwerp, Belgium

Diagnosis, management, and treatment of hepatitis C

Seroprevalence of hepatitis C virus: the first population-based study from Iran.

Pegylated interferon-alpha-2a plus ribavirin for treatment-naive Asian patients with hepatitis C virus genotype 1 infection: a multicenter, randomized controlled trial.

Safety and efficacy of locally manufactured pegylated interferon in hepatitis C patients.

P304

110-114

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P433

2

http://www.w3.org/2001/XMLSchema#string

P478

3

http://www.w3.org/2001/XMLSchema#string

P577

2011-09-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

25197541

http://www.w3.org/2001/XMLSchema#string

P921

multicenter trial

P932

4154913

http://www.w3.org/2001/XMLSchema#string